Download PDF
Semin intervent Radiol 2022; 39(02): 184-191
DOI: 10.1055/s-0042-1745764
Review Article

A Technical Guide to Palliative Ablation of Recurrent Cancers in the Deep Spaces of the Suprahyoid Neck

Terrence Chi Hong Hui
1   Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore
,
Ming Yann Lim
2   Department of Otorhinolaryngology, Tan Tock Seng Hospital, Singapore, Singapore
,
Amit Anand Karandikar
1   Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore
,
Siu Cheng Loke
1   Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore
,
Uei Pua
1   Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Treatment options for patients with recurrent head and neck cancer, whether locoregional recurrence of previously treated head and neck cancer or secondary primary malignancy, are limited. Percutaneous ablation is a minimally invasive procedure that can be used with palliative intent in the head and neck to achieve symptomatic relief and local tumor control, potentially fulfilling treatment gaps of current standard of care options. Image guidance is key when navigating the deep spaces of the neck with special attention paid to critical structures within the carotid sheath. This review article provides an overview and highlights the important nuances of performing percutaneous ablations in the head and neck. It covers general principles, ablative modalities, image guidance, procedural technique, expected outcomes, and possible complications.

Keywords

recurrent head and neck cancer - interventional radiology - cryoablation - cryoneurolysis - percutaneous thermal ablation

Disclosures

The authors have no relevant disclosures. There was no grant funding or financial support for this study.




Publication History

Article published online:
30 June 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24 (14) 2137-2150
    CrossrefPubMedGoogle Scholar
  • 2 Grégoire V, Lefebvre JL, Licitra L, Felip E. EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl. 05) v184-v186
    CrossrefPubMedGoogle Scholar
  • 3 Denaro N, Merlano MC, Russi EG. Follow-up in head and neck cancer: Do more does it mean do better? A systematic review and our proposal based on our experience. Clin Exp Otorhinolaryngol 2016; 9 (04) 287-297
    CrossrefPubMedGoogle Scholar
  • 4 Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995; 104 (12) 946-954
    CrossrefPubMedGoogle Scholar
  • 5 Kao J, Garofalo MC, Milano MT, Chmura SJ, Citron JR, Haraf DJ. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 2003; 29 (01) 21-30
    CrossrefPubMedGoogle Scholar
  • 6 Hamoir M, Schmitz S, Suarez C. et al. The current role of salvage surgery in recurrent head and neck squamous cell carcinoma. Cancers (Basel) 2018; 10 (08) E267
    CrossrefPubMedGoogle Scholar
  • 7 Temam S, Koka V, Mamelle G. et al. Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma. Head Neck 2005; 27 (08) 653-658
    CrossrefPubMedGoogle Scholar
  • 8 Guidi A, Codecà C, Ferrari D. Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review. Med Oncol 2018; 35 (03) 37
    CrossrefPubMedGoogle Scholar
  • 9 Shin DM, Glisson BS, Khuri FR. et al. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol 1998; 16 (04) 1325-1330
    CrossrefPubMedGoogle Scholar
  • 10 Shin DM, Khuri FR, Glisson BS. et al. Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma. Cancer 2001; 91 (07) 1316-1323
    CrossrefPubMedGoogle Scholar
  • 11 Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993; 328 (03) 184-194
    CrossrefPubMedGoogle Scholar
  • 12 Levy J, Hopkins T, Morris J. et al. Radiofrequency ablation for the palliative treatment of bone metastases: outcomes from the Multicenter OsteoCool Tumor Ablation Post-Market Study (OPuS One Study) in 100 patients. J Vasc Interv Radiol 2020; 31 (11) 1745-1752
    CrossrefPubMedGoogle Scholar
  • 13 Brook AL, Gold MM, Miller TS. et al. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. J Vasc Interv Radiol 2008; 19 (05) 725-735
    CrossrefPubMedGoogle Scholar
  • 14 Guenette JP, Tuncali K, Himes N, Shyn PB, Lee TC. Percutaneous image-guided cryoablation of head and neck tumors for local control, preservation of functional status, and pain relief. AJR Am J Roentgenol 2017; 208 (02) 453-458
    CrossrefPubMedGoogle Scholar
  • 15 Quek LHH, Lim MY, Cheo T, Teo HL, Pua U. Percutaneous management of recurrent head and neck cancer: current role and evolving principles in the multidisciplinary setting. Curr Oncol Rep 2021; 23 (05) 52
    CrossrefPubMedGoogle Scholar
  • 16 Gangi A, Cebula H, Cazzato RL. et al. “Keeping a cool head”: percutaneous imaging-guided cryo-ablation as salvage therapy for recurrent glioblastoma and head and neck tumours. Cardiovasc Intervent Radiol 2020; 43 (02) 172-175
    CrossrefPubMedGoogle Scholar
  • 17 Chokkappan K, Lim MY, Loke SC, Karandikar A, Pua U. Salvage cryoablation of recurrent squamous cell carcinoma for impending airway obstruction with abscopal effect. J Vasc Interv Radiol 2020; 31 (11) 1939-1942
    CrossrefPubMedGoogle Scholar
  • 18 Prologo JD, Edalat F, Moussa M. Interventional cryoneurolysis: an illustrative approach. Tech Vasc Interv Radiol 2020; 23 (04) 100698
    CrossrefPubMedGoogle Scholar
  • 19 Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee Jr FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation–what should you use and why?. Radiographics 2014; 34 (05) 1344-1362
    CrossrefPubMedGoogle Scholar
  • 20 Dar SA, Love Z, Prologo JD, Hsu DP. CT-guided cryoablation for palliation of secondary trigeminal neuralgia from head and neck malignancy. J Neurointerv Surg 2013; 5 (03) 258-263
    CrossrefPubMedGoogle Scholar
  • 21 Longo KC, Zlevor AM, Laeseke PF. et al. Histotripsy ablations in a porcine liver model: feasibility of respiratory motion compensation by alteration of the ablation zone prescription shape. Cardiovasc Intervent Radiol 2020; 43 (11) 1695-1701
    CrossrefPubMedGoogle Scholar
  • 22 Liao J, Lu M, Wu X. et al. A preliminary study on ultrasound-guided percutaneous microwave ablation for palliative treatment of advanced head and neck malignancies. Int J Hyperthermia 2021; 38 (01) 479-487
    CrossrefPubMedGoogle Scholar
  • 23 Chen YJ, Wang CP, Wang CC, Jiang RS, Lin JC, Liu SA. Carotid blowout in patients with head and neck cancer: associated factors and treatment outcomes. Head Neck 2015; 37 (02) 265-272
    CrossrefPubMedGoogle Scholar
  • 24 Lee CW, Yang CY, Chen YF, Huang A, Wang YH, Liu HM. CT angiography findings in carotid blowout syndrome and its role as a predictor of 1-year survival. AJNR Am J Neuroradiol 2014; 35 (03) 562-567
    CrossrefPubMedGoogle Scholar
  • 25 Owen RP, Silver CE, Ravikumar TS, Brook A, Bello J, Breining D. Techniques for radiofrequency ablation of head and neck tumors. Arch Otolaryngol Head Neck Surg 2004; 130 (01) 52-56
    CrossrefPubMedGoogle Scholar
  • 26 Owen RP, Khan SA, Negassa A. et al. Radiofrequency ablation of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2011; 137 (05) 493-498
    CrossrefPubMedGoogle Scholar
  • 27 Belfiore MP, Sciandra M, Romano F. et al. Preliminary results in unresectable head and neck cancer treated by radiofrequency and microwave ablation: feasibility, efficacy, and safety. J Vasc Interv Radiol 2015; 26 (08) 1189-1196
    CrossrefPubMedGoogle Scholar
  • 28 Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 2009; 58 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 29 Weymuller Jr EA, Alsarraf R, Yueh B, Deleyiannis FW, Coltrera MD. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg 2001; 127 (05) 489-493
    CrossrefPubMedGoogle Scholar